HIGH

Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1

Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.

Quick Facts at a Glance

Recall Date
September 16, 2025
Hazard Level
HIGH
Brand
IntegraDose Compounding Services
Geographic Scope
1 states

Hazard Information

Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact IntegraDose Compounding Services LLC or your healthcare provider for guidance. Notification method: Letter

Full Description

Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1. Reason: Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.. Classification: Class I. Quantity: 853/500 mL bags. Distribution: Nationwide in the USA

View Original Recall on FDA - Drug Safety

Want Alerts Like This?

Get notified about recalls in categories you care about.

Product Classification

Product Details

Model Numbers
Lot #: 20250620OXY-1
Expiration date 10/18/2025
Affected States
ALL
Report Date
October 22, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]

CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

SUCRALFATE
CGMP Deviations:
Read more